Le Lézard
Classified in: Health
Subjects: RCL, PSF

Updated Food Recall Warning (Allergen) - Yeast Brewers Debittered sold at Fountainhead Health Store recalled due to undeclared peanut


OTTAWA, Feb. 19, 2019 /CNW/ - The food recall warning issued earlier today has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Fountainhead Health Store is recalling Yeast Brewers Debittered sold in bulk from the marketplace because it contains peanut which is not declared on the label. People with an allergy to peanut should not consume the recalled product described below.

The following product has been sold in bulk at Fountainhead Health Store, 212 St. Andrew Street West, Fergus, Ontario.

Recalled product

 

Brand

Product

Size

UPC

Codes

None

Yeast Brewers Debittered

Variable ? sold in bulk

None

All products sold from October 1, 2018 up to and including February 19, 2019

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to peanut, do not consume the recalled product as it may cause a serious or life-threatening reaction.

Background

This recall was triggered by a consumer complaint. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been no reported reactions for the bulk Yeast Brewers Debittered sold at Fountainhead Health Store. However, there have been reported reactions associated with other recently recalled Brewers Yeast products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...



News published on and distributed by: